Location History:
- Pohang-si, KR (2015)
- Pohang, KR (2017)
- Seoul, KR (2016 - 2022)
Company Filing History:
5 out of 658 
2 out of 3 
1 out of 3 Years Active: 2015-2022
Title: The Innovative Contributions of Jong Hun Im in Biomedical Imaging
Introduction
Jong Hun Im, a distinguished inventor based in Seoul, South Korea, has made significant strides in the field of biomedical imaging and cancer therapeutics. With a robust portfolio that includes seven patents, his inventive work showcases his commitment to advancing medical technologies that can potentially improve patient outcomes.
Latest Patents
Among Jong Hun Im's notable patents is a groundbreaking biomolecule imaging method that employs aptamers. This method includes a composition for imaging tumorous disease regions, utilizing a fluorescence- or radioactive isotope-labeled ERBB2 aptamer to visualize these areas in vivo effectively. Another significant patent involves an aptamer-drug conjugate that serves as a cancer-targeted therapeutic agent. This patent outlines a drug-linker-AS1411 structure, which can include various potent drugs like monomethyl auristatin E (MMAE) and cytarabine, among others, demonstrating his focus on precision medicine in oncology.
Career Highlights
Jong Hun Im's career is marked by his association with the Postech Academy-Industry Foundation and Interoligo Corporation. His innovative research and development efforts have led to the creation of methodologies that bridge the gap between academia and industry, particularly in medical applications.
Collaborations
Throughout his career, Jong Hun has collaborated with esteemed colleagues such as Jung Hwan Lee and Jong In Kim. These partnerships signify the importance of teamwork and interdisciplinary approaches in advancing technology and addressing complex health challenges.
Conclusion
In conclusion, Jong Hun Im stands as a testament to the transformative power of innovation in medicine. His work not only addresses critical needs in cancer diagnostics and therapeutics but also reflects the potential of collaborations in fostering groundbreaking advancements. His contributions continue to inspire future inventors and researchers in the biomedical field.